| Matthew Christopher Hopkins, DPT | |
|
9 Lincoln Ave, Coventry, RI 02816-7748 | |
| (401) 524-7972 | |
| Not Available |
| Full Name | Matthew Christopher Hopkins |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 9 Lincoln Ave, Coventry, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780999433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | PT02321 (Rhode Island) | Secondary |
| 225100000X | Physical Therapist | PT02321 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Christopher Hopkins, DPT 9 Lincoln Ave, Coventry, RI 02816-7748 Ph: (401) 524-7972 | Matthew Christopher Hopkins, DPT 9 Lincoln Ave, Coventry, RI 02816-7748 Ph: (401) 524-7972 |
News Archive
Huron Digital Pathology announced today that the Joint Pathology Center (JPC), the premier pathology reference center for the United States federal government and part of the US Defense Health Agency, has selected Huron's artificial intelligence-enabled LagottoTM image search engine to index and search JPC's growing digital image archive.
WellPoint, Inc. (NYSE: WLP) is pleased to announce it has received a "2010 Diversity Leader Award®" in the January/February issue of Profiles in Diversity Journal for demonstrating outstanding diversity communication practices during the past year.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.
MedeAnalytics, a leading provider of healthcare performance management solutions, today announced that the Saint Barnabas Health Care System has selected MedeAnalytics Patient Access Intelligence solution to automate the complete patient access process of the health system.
Insects, such as some moths and fruit flies, react to microbial infection in the same way as mammals and so can be used to test the efficiency of new drugs, thereby reducing the need for animal testing. Dr Kevin Kavanagh from the National University of Ireland - Maynooth, presented his research findings at the Society for General Microbiology's meeting at Heriot Watt University, Edinburgh, today (8 September).
› Verified 1 days ago